跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 87,129 条关于
“HDAC1/2/3”
全部
87,129
临床试验
55,803
药物
9,792
机构
2,436
资讯
19,098
去年
Anbogen Receives FDA Clearance for Phase 1/2 Trial of ABT-301 Triplet Therapy in Metastatic Colorectal Cancer
上个月
HDAC inhibition turns cancer-cell quiescence into a druggable vulnerability against chemotherapy-resistant ovarian cancer
去年
HDAC Inhibitors Market Projected to Surge Through 2034 as Next-Generation Cancer Therapies Advance in Clinical Trials
3个月前
Automated Glioblastoma Organoid Platform Reveals Vulnerability to Proteasome and HDAC Inhibitors
去年
Lyra Therapeutics Completes Enrollment in Phase 3 Trial of LYR-210 for Chronic Rhinosinusitis
9个月前
Novo Nordisk's Amycretin Shows Promising Phase 2 Results in Type 2 Diabetes, Advances to Phase 3 Trials
去年
Bayer Advances Asundexian to Phase 3 Despite Phase 2 Efficacy Misses
11个月前
United Therapeutics Reports Phase 3 TETON-2 Trial Results in Conference Call
去年
Ocugen Initiates Phase 2/3 GARDian3 Trial for Stargardt Disease Gene Therapy
去年
Arthrosi Therapeutics Completes Enrollment in Phase 3 Trial of AR882 for Gout
第 1 页,共 1910 页
上一页
下一页